X4 Pharmaceuticals Enters $150 Million Senior Secured Loan Facility

X4 Pharmaceuticals entered a senior secured term loan facility of up to $150 million with K2 HealthVentures, replacing its previous loan agreement and expanding the company’s financing flexibility.

An $80 million tranche was funded at closing. The facility gives X4 additional access to capital under the new lending arrangement.

The agreement is structured as a senior secured term loan facility, making the initial funding available while allowing total commitments of up to $150 million.